KOLLER ANDREAS
Universitätsklinik für Augenheilkunde und Optometrie
Forschungsprogramm für experimentelle Ophthalmologie und Glaukomforschung
Publikationen
23 Publikationen
2023
Beiträge in Fachzeitschriften
Topical Diacerein Decreases Skin and Splenic CD11c
Brunner, SM; Ramspacher, A; Rieser, C; Leitner, J; Heil, H; Ablinger, M; Tevini, J; Wimmer, M; Koller, A; Piñón Hofbauer, J; Felder, TK; Bauer, JW; Kofler, B; Lang, R; Wally, V;
Int J Mol Sci. 2023; 24(5):
Originalarbeiten (Zeitschrift)
Cysteinyl leukotriene receptor 1 is a potent regulator of the endosomal-lysosomal system in the ARPE-19 retinal pigment epithelial cell line.
Koller, A; Brunner, SM; Preishuber-Pflügl, J; Runge, C; Ladek, AM; Reitsamer, HA; Trost, A;
Traffic. 2023;
Originalarbeiten (Zeitschrift)
2022
Beiträge in Fachzeitschriften
Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER
Mayr, D; Preishuber-Pflügl, J; Koller, A; Brunner, SM; Runge, C; Ladek, AM; Rivera, FJ; Reitsamer, HA; Trost, A;
Curr Eye Res. 2022; 47(4):590-596
Originalarbeiten (Zeitschrift)
2021
Beiträge in Fachzeitschriften
A spoonful of L-fucose-an efficient therapy for GFUS-CDG, a new glycosylation disorder.
Feichtinger, RG; Hüllen, A; Koller, A; Kotzot, D; Grote, V; Rapp, E; Hofbauer, P; Brugger, K; Thiel, C; Mayr, JA; Wortmann, SB;
EMBO Mol Med. 2021; 13(9): e14332
Originalarbeiten (Zeitschrift)
Chronobiological activity of cysteinyl leukotriene receptor 1 during basal and induced autophagy in the ARPE-19 retinal pigment epithelial cell line.
Koller, A; Preishuber-Pflügl, J; Runge, C; Ladek, AM; Brunner, SM; Aigner, L; Reitsamer, H; Trost, A;
Aging (Albany NY). 2021; 13(24):25670-25693
Originalarbeiten (Zeitschrift)
Intranasal Delivery of a Methyllanthionine-Stabilized Galanin Receptor-2-Selective Agonist Reduces Acute Food Intake
Kuipers, A; Balasko, M; Petervari, E; Koller, A; Brunner, SM; Moll, GN; Kofler, B
NEUROTHERAPEUTICS. 2021;
Originalarbeiten (Zeitschrift)
Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost, A; Motloch, K; Koller, A; Bruckner, D; Runge, C; Schroedl, F; Bogner, B; Kaser-Eichberger, A; Strohmaier, C; Ladek, AM; Preishuber-Pfluegl, J; Brunner, SM; Aigner, L; Reitsamer, HA;
Exp Eye Res. 2021; 213: 108806
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
The role of Cysteinyl-Leukotrienes in preeclamptic patients
Jaksch-Bogensperger, H; Koller, A; Fischer, T; Aigner, L; Fazelnia, C; Gharehbaghi, D; Zurl, A; Hillerer, KM
GEBURTSH FRAUENHEILK. 2021; 81(06): E16-E16.
Abstracts (Zeitschrift)
2020
Beiträge in Fachzeitschriften
Cysteinyl leukotriene receptor 1 modulates autophagic activity in retinal pigment epithelial cells.
Koller, A; Bruckner, D; Aigner, L; Reitsamer, H; Trost, A;
Sci Rep. 2020; 10(1): 17659
Originalarbeiten (Zeitschrift)
The Influence of Ketogenic Diets on Psoriasiform-Like Skin Inflammation.
Locker, F; Leitner, J; Aminzadeh-Gohari, S; Weber, DD; Sanio, P; Koller, A; Feichtinger, RG; Weiss, R; Kofler, B; Lang, R;
J Invest Dermatol. 2020; 140(3):707-710.e7
Letter
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Wortmann, SB; Van Hove, JLK; Derks, TGJ; Chevalier, N; Knight, V; Koller, A; Oussuren, E; Mayr, JA; van Spronsen, FJ; Lagler, FB; Gaughan, S; Van Schaftingen, E; Veiga-da-Cunha, M;
Blood. 2020; 136(9): 1033-1043.
Originalarbeiten (Zeitschrift)
2019
Beiträge in Fachzeitschriften
Validation of antibody-based tools for galanin research.
Brunner, SM; Koller, A; Stockinger, J; Locker, F; Leis, S; Ernst, F; Strasser, P; Brodowicz, B; Ebner, S; Holub, BS; Rauch, I; Graf, K; Lang, R; Kofler, B;
Peptides. 2019; 120: 170009
Originalarbeiten (Zeitschrift)
Galanin is a potent modulator of cytokine and chemokine expression in human macrophages.
Koller, A; Brunner, SM; Bianchini, R; Ramspacher, A; Emberger, M; Locker, F; Schlager, S; Kofler, B;
Sci Rep. 2019; 9(1): 7237
Originalarbeiten (Zeitschrift)
Influence of the regulatory peptide galanin on cytokine expression in human monocytes.
Ramspacher, A; Neudert, M; Koller, A; Schlager, S; Kofler, B; Brunner, SM;
Ann N Y Acad Sci. 2019; 1455(1): 185-195.
Originalarbeiten (Zeitschrift)
2018
Beiträge in Fachzeitschriften
Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression.
Locker, F; Vidali, S; Holub, BS; Stockinger, J; Brunner, SM; Ebner, S; Koller, A; Trost, A; Reitsamer, HA; Schwarzenbacher, D; Lang, R; Kofler, B;
J Invest Dermatol. 2018; 138(1):199-207
Originalarbeiten (Zeitschrift)
NDUFB8 Mutations Cause Mitochondrial Complex I Deficiency in Individuals with Leigh-like Encephalomyopathy.
Piekutowska-Abramczuk, D; Assouline, Z; Mataković, L; Feichtinger, RG; Koňařiková, E; Jurkiewicz, E; Stawiński, P; Gusic, M; Koller, A; Pollak, A; Gasperowicz, P; Trubicka, J; Ciara, E; Iwanicka-Pronicka, K; Rokicki, D; Hanein, S; Wortmann, SB; Sperl, W; Rötig, A; Prokisch, H; Pronicka, E; Płoski, R; Barcia, G; Mayr, JA;
Am J Hum Genet. 2018; 102(3):460-467
Originalarbeiten (Zeitschrift)
2017
Beiträge in Fachzeitschriften
The neuropeptide galanin modulates natural killer cell function.
Koller, A; Bianchini, R; Schlager, S; Münz, C; Kofler, B; Wiesmayr, S;
Neuropeptides. 2017; 64: 109-115.
Originalarbeiten (Zeitschrift)
The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome
Vidali, S; Aminzadeh-Gohari, S; Feichtinger, RG; Vatrinet, R; Koller, A; Locker, F; Rutherford, T; O'Donnell, M; Stoger-Kleiber, A; Lambert, B; Felder, TK; Sperl, W; Kofler, B
ONCOTARGET. 2017; 8(34): 57201-57215.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
The role of the galanin system in psoriasis-like skin inflammation
Locker, F; Vidali, S; Holub, B; Stockinger, J; Koller, A; Brunner, S; Schwarzenbacher, D; Lang, R; Kofler, B
J INVEST DERMATOL. 2017; 137(10): S253-S253.
Abstracts (Zeitschrift)
2016
Beiträge in Fachzeitschriften
In vitro toxicity of the galanin receptor 3 antagonist SNAP 37889.
Koller, A; Rid, R; Beyreis, M; Bianchini, R; Holub, BS; Lang, A; Locker, F; Brodowicz, B; Velickovic, O; Jakab, M; Kerschbaum, H; Önder, K; Kofler, B;
Neuropeptides. 2016; 56:83-88
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
The role of galanin receptor 3 in psoriasis-like skin inflammation
Locker, F; Vidali, S; Holub, B; Koller, A; Brunner, S; Schwarzenbacher, D; Lang, R; Kofler, B
J INVEST DERMATOL. 2016; 136(9): S216-S216.
Abstracts (Zeitschrift)
2015
Beiträge in Fachzeitschriften
Galanin modulates human and murine neutrophil activation in vitro.
Locker, F; Lang, AA; Koller, A; Lang, R; Bianchini, R; Kofler, B;
Acta Physiol (Oxf). 2015; 213(3):595-602
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Contribution of the galanin system to inflammation
Kofler, B; Brunner, S; Koller, A; Wiesmayr, S; Locker, F; Lang, R; Botz, B; Kemeny, A; Helyes, Z
SPRINGERPLUS. 2015; 4:
Abstracts (Zeitschrift)